LIFEMD, INC. (LFMD) Gross Margin
- Gross margin · 12 months: Value 87.50%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 87.50% | Gross profit / revenue. Period ending 2026-06-30. $167.64M ÷ $191.59M × 100 ≈ 87.50% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 167.64M USD | Gross Profit |
| Revenue | 191.59M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $167.64M | $191.59M | (m) | 87.50% |
| 2026-03-31 | $167.83M | $193.33M | (m) | 86.81% |
| 2025-12-31 | $166.34M | $194.06M | (m) | 85.72% |
| 2025-09-30 | $213.56M | $246.48M | (m) | 86.65% |
| 2025-06-30 | $215.05M | $245.56M | (m) | 87.57% |
| 2025-03-31 | $205.90M | $234.01M | (m) | 87.99% |
| 2024-12-31 | $188.39M | $212.45M | (m) | 88.67% |
| 2024-09-30 | $173.06M | $193.06M | (m) | 89.64% |
| 2024-06-30 | $158.52M | $178.28M | (m) | 88.92% |
| 2024-03-31 | $144.28M | $163.56M | (m) | 88.21% |
| 2023-12-31 | $133.65M | $152.55M | (m) | 87.61% |
| 2023-09-30 | $118.19M | $135.81M | (m) | 87.03% |
| 2023-06-30 | $111.06M | $128.61M | (m) | 86.36% |
| 2023-03-31 | $105.48M | $123.12M | (m) | 85.68% |
| 2022-12-31 | $100.37M | $119.03M | (m) | 84.32% |
| 2022-09-30 | $98.16M | $118.33M | (m) | 82.96% |
| 2022-06-30 | $91.32M | $111.87M | (m) | 81.63% |
| 2022-03-31 | $83.69M | $103.72M | (m) | 80.69% |
| 2021-12-31 | $74.88M | $92.88M | (m) | 80.62% |
| 2021-09-30 | $61.94M | $78.35M | (m) | 79.05% |
| 2021-06-30 | $51.07M | $64.41M | (m) | 79.29% |
| 2021-03-31 | $40.35M | $51.19M | (m) | 78.84% |
| 2020-12-31 | $28.39M | $37.29M | (m) | 76.12% |
| 2020-09-30 | $20.40M | $15.96M | (m) | 127.84% |
| 2020-06-30 | $14.58M | $8.08M | (m) | 180.41% |
| 2020-03-31 | $9.76M | $1.69M | (m) | 577.53% |
| 2019-12-31 | $9.20M | $83.55K | (m) | 11008.56% |
| 2019-09-30 | $8.06M | $10.71M | (m) | 75.23% |
| 2019-06-30 | $7.67M | $10.08M | (m) | 76.06% |
| 2019-03-31 | $7.13M | $9.42M | (m) | 75.66% |
| 2018-12-31 | $6.36M | $8.32M | (m) | 76.35% |
| 2018-09-30 | $5.87M | (m) | (m) | (m) |
| 2018-06-30 | $5.33M | (m) | (m) | (m) |
| 2018-03-31 | $4.74M | (m) | (m) | (m) |
| 2017-12-31 | $3.57M | (m) | (m) | (m) |
| 2017-09-30 | $2.82M | (m) | (m) | (m) |
| 2017-06-30 | $3.46M | (m) | (m) | (m) |
| 2017-03-31 | $3.21M | (m) | (m) | (m) |
| 2016-12-31 | $3.29M | (m) | (m) | (m) |
| 2016-09-30 | $1.63M | $4.63M | (m) | 35.33% |
| 2016-06-30 | $1.40M | $3.52M | (m) | 39.71% |
| 2016-03-31 | $1.06M | $2.57M | (m) | 41.22% |
| 2015-12-31 | $971.09K | $1.22M | (m) | 79.67% |
| 2015-09-30 | $784.46K | $1.01M | (m) | 78.04% |
| 2015-06-30 | $672.42K | $890.75K | (m) | 75.49% |
| 2015-03-31 | $612.03K | $810.01K | (m) | 75.56% |
| 2014-12-31 | $541.31K | $714.16K | (m) | 75.80% |
| 2014-09-30 | $521.01K | $715.03K | (m) | 72.87% |
| 2014-06-30 | $479.45K | $644.24K | (m) | 74.42% |
| 2014-03-31 | $593.04K | $770.53K | (m) | 76.96% |
| 2013-12-31 | $627.06K | $808.36K | (m) | 77.57% |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) |
| 2012-12-31 | $473.87K | $673.78K | (m) | 70.33% |
| 2012-09-30 | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |